Avenue Therapeutics, Inc. - ATXI

About Gravity Analytica
Recent News
- 01.06.2026 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
- 01.06.2026 - 4 - Statement of changes in beneficial ownership of securities
- 12.31.2025 - 8-K - Current report
- 12.17.2025 - EFFECT - Notice of Effectiveness
- 12.15.2025 - POS AM - Post-effective amendment to a registration statement that is not immediately effective upon filing
- 12.15.2025 - RW - Registration Withdrawal Request
- 12.05.2025 - DEF 14A - Definitive proxy statements
- 11.18.2025 - 8-K - Current report
- 11.13.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
- 11.12.2025 - 8-K - Current report
Recent Filings
- 12.31.2025 - 8-K Current report
- 12.16.2025 - EFFECT Notice of Effectiveness
- 12.15.2025 - RW Registration Withdrawal Request
- 12.15.2025 - POS AM Post-Effective amendments for registration statement
- 12.05.2025 - DEF 14A Other definitive proxy statements
- 11.18.2025 - 8-K Current report
- 11.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 11.12.2025 - 8-K Current report
- 11.12.2025 - EX-99.1 EX-99.1